Weijian Huang

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens

Gongbo Fu, Weijian Huang, Min Zeng et al. · Cell Research · 2018 · 175 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Association Between Sex-Specific Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Chinese Adults

Shengjie Wu, Gui‐Qi Zhu, Bozhi Ye et al. · Medicine · 2015 · 63 citations · Full text

Public Health, Endocrinology, Clinical Epidemiology +14

Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2

Chen‐Jie Qin, Linghao Zhao, Xu Zhou et al. · Cancer Letters · 2018 · 58 citations

Medicine, Oncology, Pharmacology +12